AdvanSix (ASIX) Stock Forecast & Price Target

AdvanSix is viewed positively because cheaper natural gas versus Western Europe and much of Asia supports a structural cost advantage that should strengthen margins as fertilizer and other demand normalizes. The business is also benefiting from improved Nylon/Caprolactam and Chemical Intermediates fundamentals, including 2Q revenue of $178 million versus $152 million one year earlier, stable CI volumes and spreads, and Nylon margin expansion from a more favorable domestic mix despite weak end-demand. In addition, the $47.4 million USDA grant for Project CENTURY lowers AdvanSix’s out-of-pocket cost to about $51 million while adding roughly 84,000 tons of annual ammonia capacity, and together with $100 million-$120 million in expected Section 45Q credits and targeted $30 million structural cost improvements by the end of 2027, these catalysts support higher earnings and cash flow.

AdvanSix is facing a deteriorating earnings profile as 3Q26 adjusted EPS missed expectations at a loss of ($0.24) versus a consensus loss of ($0.05), while adjusted EBITDA fell to $15 million from $25 million in 3Q25 despite revenue rising to $431 million. The core weakness is Plant Nutrients, where seasonally soft ammonium sulfate pricing and record-high sulfur costs drove sharply lower profitability, with Tampa sulfur peaking at $705/mt in 3Q26 and still settling at $615/mt in late October, keeping margin pressure elevated. Although nylon, caprolactam, and acetone showed modest improvement and Section 45Q credits plus a FIELDS grant may support cash flow, weaker FY26 and 2027 estimates, cyclical end-market exposure, and a history of outages leave the fundamentals under strain.